Further, a recent study has indicated the carcinogenic role of NF-κB in HCC, suggesting that inhibition of the NF-κB pathway can prevent the malignant progression of HCC (Dai et al., 2022). Here, NFKB1 is linked to hepatocellular carcinoma.